Magnesium sulfate versus ipratropium bromide in chronic obstructive pulmonary disease exacerbation: A randomized trial

American Journal of Therapeutics

Volumn 21, Issue 3, 2014, Pages 152-158

  Nouira, Semir ^a   Bouida, Wahid ^a   Grissa, Mohamed H ^a   Beltaief, Kaouther ^a   Trimech, Mohamed N ^a   Boubaker, Hamdi ^a   Marghli, Soudani ^b   Letaief, Mondher ^c   Boukef, Riadh ^a  

^a Fattouma Bourguiba Monastir   (Tunisia)

^b Tahar Sfar University Hospital   (Tunisia)

^c UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

acute exacerbation of chronic obstructive pulmonary disease; emergency department; magnesium sulfate

Indexed keywords

IPRATROPIUM BROMIDE; MAGNESIUM SULFATE; PLACEBO; TERBUTALINE; BRONCHODILATING AGENT;

AGED; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG ERUPTION; DRUG INDUCED HEADACHE; DYSPNEA; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEBULIZATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREMOR; UNSPECIFIED SIDE EFFECT; BLOOD GAS ANALYSIS; COMPARATIVE STUDY; DRUG EFFECTS; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA; TIME;

ADMINISTRATION, INHALATION; AGED; BLOOD GAS ANALYSIS; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; IPRATROPIUM; MAGNESIUM SULFATE; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TIME FACTORS;

EID: 84900827616     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3182459a8e     Document Type: Article

References (23)

1. Murray GJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet. 1997;349:1498-1504.
2. Niederman MS, McCombs JS, Unger AN, et al. Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther. 1999;21:576-591.
3. Yuze PJ, Steven MU, Hans PG, et al. Oral or IV prednisolone in the treatment of COPD exacerbations. A randomized, controlled, double-blind study. Chest. 2007;132:1741-1747.
4. Kunisaki KM, Rice KL, Niewoehner DE. Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: an appraisal of published evidence. Drugs Aging. 2007;24:303-324.
5. Rebuck AS, Chapman KR, Abboud R, et al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive pulmonary disease in the emergency room. Am J Med. 1987;82:59-64.
6. ODriscoll BR, Taylor RJ, Horsley MG, et al. Nebulized salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet. 1989;1:1418-1420.
7. PatrickDM, Dales RE, Stark RM, et al. Severe exacerbations of COPD and asthma: incremental benefit of adding ipratropium to usual therapy. Chest. 1990;98:295-297.
8. Shrestha M, OBrien T, Haddox R, et al. Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to beta-Agonist therapy. Ann Emerg Med. 1991;20:1206-1209.
9. Moayyedi P, Congleton J, Page RL, et al. Comparison of nebulized salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. Thorax. 1995;50:834-837.
10. Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-Analysis. Emerg Med J. 2007;24:823-830.
11. Skorodin MS, Tenholder MF, Yetter B, et al. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 1995;155:496-500.
12. Skobeloff EM, Spivey WH, McNamara RM, et al. Intravenous magnesium sulphate for the treatment of acute asthma in the emergency department. JAMA. 1989;262: 1210-1213.
13. Dominguez LJ, Barbgallo M, Di Lorenzo G, et al. Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma. Clin Sci. 1998;95:137-142.
14. Spivy WH, Skobelof EM, Levin RM. Effect of Mg chloride on rabbit bronchial smooth muscle. Ann Emerg Med. 1990; 19:1107-1112.
15. Dhingra S, Solven F, Wilson A, et al. Hypomagnesemia and respiratory muscle power. Am Rev Respir Dis. 1984; 129:497-498.
16. Alamoudi OS. Hypomagnesaemia in chronic, stable asthmatics: prevalence, correlation with severity and hospitalization. Eur Respir J. 2000;16:427-431.
17. Aziz HS, Blamoun AI, Shubair MK, et al. Serum magnesium levels and acute exacerbation of chronic obstructive pulmonary disease: a retrospective study. Ann Clin Lab Sci. 2005;35:423-427.
18. Silverman RA, Osborn H, Runge J, et al; Acute Asthma/Magnesium Study Group. IV magnesium sulphate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest. 2002;122: 489-497.
19. Viskin S, Belhassen B, Laniado S. Deterioration of ventricular tachycardia to ventricular fibrillation after rapid intravenous administration of magnesium sulfate. Chest. 1992;101:1445-1447.
20. Clark BA, Brown RS. Unsuspected morbid hypermagnesemia in elderly patients. Am J Nephrol. 1992;12: 336-343.
21. Gonzalez JA, Garcia CH, Gonzalez PA, et al. Effect of intravenous magnesium sulfate on chronic obstructive pulmonary disease exacerbations requiring hospitalization: a randomized placebo-controlled trial. Arch Bronconeumol. 2006;42:384-387.
22. Skorodin MS, Freebeck PC, Yetter B, et al. Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline. Chest. 1994;105:701-705.
23. Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med. 2000; 161:1862-1868